Omnicell Announces Fourth Quarter and Full-Year 2009 Results

January 28, 2010

MOUNTAIN VIEW, Calif.

PRNewswire via COMTEX News Network-- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, today announced results for its fourth quarter and year ended December 31, 2009.

GAAP results: Revenue for the fourth quarter of 2009 was $54.7 million, up $0.7 million or 1.3% from the third quarter of 2009, and down $7.4 million or 11.9% from the fourth quarter of 2008. Revenue for the year ended December 31, 2009 was $213.5 million, down $38.4 million or 15.2% from the year ended December 31, 2008.

Fourth quarter 2009 net income as reported in accordance with U.S. generally accepted accounting principles (GAAP) was $0.6 million, or $0.02 per diluted share. This compares to net income of $0.9 million, or $0.03 per diluted share in the third quarter of 2009 and net income of $3.3 million, or $0.10 per diluted share in the fourth quarter of 2008. For the year ended December 31, 2009, net income was $0.4 million, or $0.01 per diluted share. This compares to net income of $12.7 million, or $0.38 per diluted share for the year ended December 31, 2008.

Non-GAAP results: Excluding the impact on our results of recording $2.5 million in stock-based compensation expense related to ASC 718, "Stock Compensation" (formerly referred to as SFAS No. 123R) and $0.4 million in income tax expense related to prior year research and development tax credits, non-GAAP net income was $3.4 million for the fourth quarter of 2009, or $0.11 per diluted share....

Read entire article.